Golimumab Subcutaneous and Granisetron Extended-Release Injection
Determining the interaction of Golimumab Subcutaneous and Granisetron Extended-Release Injection and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: golimumab
Brand name: Simponi, Simponi SmartJect, Simponi Aria
Synonyms: Golimumab
Generic Name: granisetron
Brand name: Sustol, Kytril, Sancuso
Synonyms: Granisetron
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Golimumab Subcutaneous-Granisetron Hydrochloride
- Golimumab Subcutaneous-Granisetron injection
- Golimumab Subcutaneous-Granisetron Oral, Intravenous
- Golimumab Subcutaneous-Granisetron Tablets
- Golimumab Subcutaneous-Granisetron transdermal
- Golimumab Subcutaneous-Granisetron Transdermal System
- Granisetron Extended-Release Injection-GoLYTELY
- Granisetron Extended-Release Injection-Gonadorelin
- Granisetron Extended-Release Injection-Gonadorelin Intravenous, Injection
- Granisetron Extended-Release Injection-Gonadotropin, Chorionic
- Granisetron Extended-Release Injection-Gonal-F
- Granisetron Extended-Release Injection-Gonal-f RFF